Ion Channels in Drug Discovery and Development

Venue: Philadelphia, PA

Location: Philadelphia, PA, United States

Event Date/Time: Jul 14, 2003
Report as Spam

Description

Presentations by:

Abbott Laboratories
Aurora Biomed
Aventis Pharmaceuticals
Aviva Biosciences
Axon Instruments
Bristol – Myers Squibb
Chantest
Eli Lilly
Evotec OAI AG
Icagen Inc.
Ionix Pharmaceuticals
Max – Planck – Institute for Experimental Medicine
Merck Research Labs
Molecular Devices
Nanion Technologies GMBH
Neuromed Technologies
Neurosearch A/S
NIEHS/NIH/DHHS
Scion Pharmaceuticals
Sophion Bioscience A/S
Vertex Pharmaceuticals
Xention Discovery

Highlights:

Keynote Address: The EAG Potassium Channel: A New Cancer Target
Walter Stuhmer, Ph.D., Professor, Molecular Biology of Neuronal Signals
The Max Planck Institute for Experimental Medicine

Regulation of Nicotinic Receptors by Cholinesterase Inhibitors in Rat Hippocampal Interneurons
Jerrel Yakel, Ph.D, Senior Investigator, Laboratory of Signal Transduction
NIEHS/NIH/DHHS

Automated High Throughput Patch Clamp Electrophysiology for Drug Discovery
Wilhelm Lachnit, Ph.D., Business Director, IonWorks Business Unit
Molecular Devices

Venue